Principal Investigator in Pediatric Leukemia
The Children´s Cancer Research Institute (www.science.ccri.at) announces recruitment for a research group leader position in pediatric leukemia.
The leukemia program is embedded in the vibrant multidisciplinary environment of one of the leading pediatric hematology/oncology centers in Europe and the largest pediatric research and treatment center in Austria. Basic, translational and clinical leukemia research has a long tradition with a leading involvement of the hospital and the CCRI in BFM treatment protocols since the 1970’s, stem cell transplantation, and leukemia genetics. Together, the physically adjacent CCRI and St. Anna Children´s Hospital provide a unique and successful combination of basic and clinical research, diagnostics, clinical trial management and up-to-date clinical care.
The Principal Investigator is expected to lead a competitive independent pediatric leukemia research program. The successful applicant will hold an MD and/or PhD degree and have at least five years of postdoctoral research experience. Scientific excellence of an independent research program with a potential for clinical translation and strong publication and funding track records are necessary requirements.
Successful applicants will be offered an attractive salary, a competitive startup package, and an initial five-year contract with the perspective of extension and tenure. There is also the possibility for part-time involvement in patient care.
The CCRI is a multidisciplinary academic research institution closely affiliated with the biggest Austrian pediatric oncological center, St. Anna Children´s Hospital, and thus with the Medical University of Vienna. The St. Anna Children´s Hospital is Austria´s leading pediatric cancer center. The paramount aim of the CCRI is to improve treatment outcome of malignant diseases in children and adolescents by performing basic, translational and clinical research. The CCRI is particularly strong in leukemia, neuroblastoma, and sarcoma research, tumor and transplantation immunology. The Institute is equipped with state-of-the-art flow cytometry, confocal microscopy, bioinformatics, zebrafish, GMP, and instrumentation core facilities as well as a biobank and a clinical study center that leads several international and national clinical trials including the Austrian pediatric ALL and AML studies.
The Institute also has close collaborations with several outstanding basic research institutes--the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences, and the Institute of Molecular Pathology (IMP). Close proximity to the St. Anna Children´s Hospital facilitates the interaction that has always been the strength of CCRI, providing an opportunity for development of experimental therapeutic approaches and investigator-initiated clinical trials. Situated in the center of Vienna, one of Europe’s most important places for medical research and life sciences and cited as the most livable city in the world, CCRI is tightly connected to St. Anna Children´s Hospital and the Medical University of Vienna.
Applications including a motivation letter, synopsis of the research program, curriculum vitae, and three references shall be addressed to the Scientific Director Dr. Kaan Boztug and the Institute Director Dr. Wolfgang Holter, e-mail: email@example.com Documented scientific excellence and a competitive innovative research program will be the prime criteria for selection of the successful candidate.